Atria Investments LLC Nevro Corp Transaction History

Atria Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $71,423 - $146,763	-1,017 Reduced 25.36%	2,993 $299,000
Q4 2019 Feb 11, 2020	BUY	$76.41 - $117.54 $6,036 - $9,285	79 Added 2.01%	4,010 $471,000
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $49,831 - $73,791	810 Added 25.95%	3,931 $338,000
Q2 2019 Aug 26, 2019	BUY	$58.04 - $66.99 $64,134 - $74,023	1,105 Added 54.81%	3,121 $250,000
Q2 2019 Aug 09, 2019	BUY	$58.04 - $66.99 $117,008 - $135,051	2,016 New	2,016 $267,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Atria Investments LLC with notifications on news.